You are here: Industry Insights > GlobalData

News List

Clinical trial disruption from COVID-19 beginning to lessen, says report europeanpharmaceuticalreview
June 22, 2020
New findings reveal that the 200 clinical trials impacted and delayed by COVID-19 are now continuing or have completed their course.
Acute myeloid leukaemia market to reach $5.1 billion by 2029: GlobalData expresspharma
June 22, 2020
This growth will be driven by label expansions of the already successful drugs Venclexta, Tibsovo, Idhifa and Xospata, as well as by a strong late-stage pipeline.
Double digit MCap growth in 2019 for 14 of top 20 pharma companies: GlobalData expresspharma
June 19, 2020
Among the positive performances were Takeda Pharmaceutical and Daiichi Sankyo, which reported more than 100 per cent YoY growth in their market caps.
COVID-19 disruption of clinical trials starting to slow: GlobalData expresspharma
June 18, 2020
FDA issued guidance recommends methods that could help keep the research going which includes virtual visits, phone interviews, self-administration, and remote monitoring.
3D Printing in Healthcare: Timeline pharmaceutical-technology
June 17, 2020
Since its inception in 1984, 3D printing has come a long way. Although it makes up less than 1% of the global manufacturing market, the industry is on an upward curve.
Psoriasis digital landscape for patients in Japan offers competent patient engagement: says GlobalDa expresspharma
June 03, 2020
According to GlobalData’s Epidemiology and Market Size Database, the value of the plaque psoriasis market in Japan is estimated to be $627.23m.
Indian pharma companies looking to leverage opportunities in drug repurposing: GlobalData expresspharma
June 03, 2020
The Drug Controller General of India (DCGI) has recently given approval to Indian pharma companies Glenmark and Strides Pharma Science to initiate clinical trials of favipiravir for COVID-19 patients.
Report reveals CMOs in Italy concentrated in worst-hit COVID-19 regions europeanpharmaceuticalreview
May 21, 2020
According to findings, the majority of CMOs in Italy are found in the locations hit worst by COVID-19, meaning the pharma supply chain has been greatly impacted.
COVID-19 effect will boost infectious disease drug approvals expresspharma
May 19, 2020
It will present more opportunities to CMOs informs GlobalData, highlighting that in early May, there were 312 novel pipeline drugs for COVID-19, of which 11 were in Phase III trials.
COVID-19 continues to disrupt clinical trials expresspharma
May 18, 2020
69.9 per cent of disruptions due to the suspension of enrolment, informs a GlobalData study.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page